BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kazdal D, Hofman V, Christopoulos P, Ilié M, Stenzinger A, Hofman P. Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice and diagnostic implications. Genes Chromosomes Cancer 2022. [PMID: 34997651 DOI: 10.1002/gcc.23022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Zhou X, Wang Z, Lu T, Li B, Jiang S. Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression. Evid Based Complement Alternat Med 2022;2022:3032087. [PMID: 35664943 DOI: 10.1155/2022/3032087] [Reference Citation Analysis]
2 Ilié M, Hofman V, Bontoux C, Heeke S, Lespinet-fabre V, Bordone O, Lassalle S, Lalvée S, Tanga V, Allegra M, Salah M, Bohly D, Benzaquen J, Marquette C, Long-mira E, Hofman P. Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France). Cancers 2022;14:2258. [DOI: 10.3390/cancers14092258] [Reference Citation Analysis]
3 Bontoux C, Hofman V, Brest P, Ilié M, Mograbi B, Hofman P. Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner. Cancers (Basel) 2022;14:1628. [PMID: 35406400 DOI: 10.3390/cancers14071628] [Reference Citation Analysis]